Search results
Results from the WOW.Com Content Network
Posaconazole, sold under the brand name Noxafil among others, is a triazole antifungal medication. [ 7 ] [ 8 ] It was approved for medical use in the European Union in October 2005, [ 6 ] and in the United States in September 2006.
Roblox occasionally hosts real-life and virtual events. They have in the past hosted events such as BloxCon, which was a convention for ordinary players on the platform. [46] Roblox operates annual Easter egg hunts [52] and also hosts an annual event called the "Bloxy Awards", an awards ceremony that also functions as a fundraiser. The 2020 ...
The online video game platform and game creation system Roblox has numerous games (officially referred to as "experiences") [1] [2] created by users of its creation tool, Roblox Studio. Due to Roblox ' s popularity, various games created on the site have grown in popularity, with some games having millions of monthly active players and 5,000 ...
Posaconazole has been frequently reported to be the most active antifungal agent available against the zygomycetes (and zygomycosis), a Class of fungi extremely refractory to current chemotherapy. That is, perhaps, its most defining and interesting feature.
Itraconazole has a broader spectrum of activity than fluconazole (but not as broad as voriconazole or posaconazole). In particular, it is active against Aspergillus, which fluconazole is not. It is also licensed for use in blastomycosis, sporotrichosis, histoplasmosis, and onychomycosis.
The following other wikis use this file: Usage on ar.wikipedia.org بوساكونازول; Usage on azb.wikipedia.org پوساکونازول; Usage on eo.wikipedia.org
"Cardboard War-Machines"), or simply LBX, is a series of action role-playing video games created by Level-5, involving small plastic model robots known as LBXs (standing for "Little Battler eXperience") that fight on dioramas made out of cardboard, with the main character setting out to battle against LBXs created by other characters.
Ravuconazole (codenamed BMS-207147 and ER-30346) is a potent triazole antifungal, the development of which was discontinued in 2007. [1] The drug has shown to have a similar spectrum of activity to voriconazole, with an increased half-life. [2]